Changes in serum fibronectin levels predict tumor recurrence in patients with early hepatocellular carcinoma after curative treatment

Fibronectin, a matrix glycoprotein aberrantly expressed in various tumor cells, is a known candidate biomarker for the early diagnosis of hepatocellular carcinoma (HCC). In this study, we investigated whether serum fibronectin levels could predict tumor recurrence in patients with early-stage HCC af...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sun Ah, Cho, Eun Ju, Lee, Sungyoung, Cho, Young Youn, Kim, Boram, Yoon, Jung-Hwan, Park, Taesung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719187/
https://www.ncbi.nlm.nih.gov/pubmed/33277619
http://dx.doi.org/10.1038/s41598-020-78440-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719187/
https://www.ncbi.nlm.nih.gov/pubmed/33277619
http://dx.doi.org/10.1038/s41598-020-78440-w

Ejemplares similares